GreenBone Ortho today announces that it has achieved its aim of recruiting 15 patients into the GreenBRIC study. GreenBRIC study is a prospective, open label, single-arm, […]
GreenBone Ortho SpA has completed a EURO 10 million Round B of investment fully covered by current shareholders – 3B Future Health Fund, Innogest SGR, Meta […]
GreenBone Ortho SpA announces its worldwide partnership with Clinica Mobile for the 2021 season. Clinica Mobile is the medical and physiotherapy group of the MotoGP and […]
With the approval of the CE mark, GreenBone officially enters the market with a completely innovative product, which provides orthopedic surgeons and traumatologists with an alternative […]
GreenBone Ortho Srl will attend the 12th edition of the “Trauma Meeting” organized by the O.T.O.D.I. Society at the Palazzo Dei Congressi in Riccione (RN) from […]
Caution
You are entering an area containing information intended for healthcare professionals. If you are a healthcare professional, click here to continue.
GreenBoneTM Bone Substitute received CE mark approval
This site uses technical cookies and third-party cookies, necessary for its operation and useful for the purposes illustrated in the privacy and cookie policy. If you want to learn more or opt out of all or some cookies see the privacy and cookie policy. By clicking on the OK button, scrolling this page or continuing the navigation in any other way, you consent to the use of cookies. OkPrivacy e Cookie Policy
